Seeing Is Believing
Currently out of the existing stock ratings of Harry Goad, 25 are a BUY (60.98%), 13 are a HOLD (31.71%), 3 are a SELL (7.32%).
Analyst Harry Goad, currently employed at BERENBERG, carries an average stock price target met ratio of 56.25% that have a potential upside of 29.46% achieved within 307 days. Previously, Harry Goad worked at LIFESCI.
Harry Goad’s has documented 73 price targets and ratings displayed on 9 stocks. The coverage is on Basic Materials, Healthcare, Consumer Cyclical, Industrials sectors.
Most recent stock forecast was given on CRH, CRH PLC ADR at 19-Aug-2025.
Analyst best performing recommendations are on BZ (KANZHUN LTD ADR).
The best stock recommendation documented was for BZ (KANZHUN LTD ADR) at 2/18/2022. The price target of $28.34 was fulfilled within 13 days with a profit of $4.36 (13.33%) receiving and performance score of 10.26.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 08-Jul-2026
$132
$32.13 (32.17%)
$135
21 days ago
(08-Jul-2026)
0/7 (0%)
$29.05 (28.22%)
Buy Since 26-Aug-2025
$140
$27.68 (24.64%)
$135
4 months 26 days ago
(03-Mar-2026)
1/3 (33.33%)
$26.85 (23.73%)
136
Buy Since 11-Nov-2024
$141
$28.68 (25.53%)
$140
4 months 27 days ago
(02-Mar-2026)
14/17 (82.35%)
$23.69 (20.19%)
361
Buy Since 20-Oct-2023
$155
$42.68 (38.00%)
$141
6 months 21 days ago
(08-Jan-2026)
8/10 (80%)
$30.79 (24.79%)
188
Hold Since 08-Aug-2025
$116
$3.68 (3.28%)
$110
8 months 17 days ago
(12-Nov-2025)
8/8 (100%)
$3.38 (3.00%)
158
What Year was the first public recommendation made by Harry Goad?